Find information on thousands of medical conditions and prescription drugs.

Hemoglobinopathy

Hemoglobinopathy is a kind of genetic defect that results in abnormal structure of one of the globin chains of the hemoglobin molecule. It is a collection of a number of diseases, including sickle-cell disease and thalassemia. Symptoms vary for the different diseases: in sickle cell disease the red blood cells tend to assume a different shape under anaerobic conditions, leading to organ damage and circulatory problems, while in thalassemia there is ineffective production of red blood cells (ineffective erythropoiesis). more...

Home
Diseases
A
B
C
D
E
F
G
H
Hairy cell leukemia
Hallermann Streiff syndrome
Hallux valgus
Hantavirosis
Hantavirus pulmonary...
HARD syndrome
Harlequin type ichthyosis
Harpaxophobia
Hartnup disease
Hashimoto's thyroiditis
Hearing impairment
Hearing loss
Heart block
Heavy metal poisoning
Heliophobia
HELLP syndrome
Helminthiasis
Hemangioendothelioma
Hemangioma
Hemangiopericytoma
Hemifacial microsomia
Hemiplegia
Hemoglobinopathy
Hemoglobinuria
Hemolytic-uremic syndrome
Hemophilia A
Hemophobia
Hemorrhagic fever
Hemothorax
Hepatic encephalopathy
Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatoblastoma
Hepatocellular carcinoma
Hepatorenal syndrome
Hereditary amyloidosis
Hereditary angioedema
Hereditary ataxia
Hereditary ceroid...
Hereditary coproporphyria
Hereditary elliptocytosis
Hereditary fructose...
Hereditary hemochromatosis
Hereditary hemorrhagic...
Hereditary...
Hereditary spastic...
Hereditary spherocytosis
Hermansky-Pudlak syndrome
Hermaphroditism
Herpangina
Herpes zoster
Herpes zoster oticus
Herpetophobia
Heterophobia
Hiccups
Hidradenitis suppurativa
HIDS
Hip dysplasia
Hirschsprung's disease
Histoplasmosis
Hodgkin lymphoma
Hodgkin's disease
Hodophobia
Holocarboxylase...
Holoprosencephaly
Homocystinuria
Horner's syndrome
Horseshoe kidney
Howell-Evans syndrome
Human parvovirus B19...
Hunter syndrome
Huntington's disease
Hurler syndrome
Hutchinson Gilford...
Hutchinson-Gilford syndrome
Hydatidiform mole
Hydatidosis
Hydranencephaly
Hydrocephalus
Hydronephrosis
Hydrophobia
Hydrops fetalis
Hymenolepiasis
Hyperaldosteronism
Hyperammonemia
Hyperandrogenism
Hyperbilirubinemia
Hypercalcemia
Hypercholesterolemia
Hyperchylomicronemia
Hypereosinophilic syndrome
Hyperhidrosis
Hyperimmunoglobinemia D...
Hyperkalemia
Hyperkalemic periodic...
Hyperlipoproteinemia
Hyperlipoproteinemia type I
Hyperlipoproteinemia type II
Hyperlipoproteinemia type...
Hyperlipoproteinemia type IV
Hyperlipoproteinemia type V
Hyperlysinemia
Hyperparathyroidism
Hyperprolactinemia
Hyperreflexia
Hypertension
Hypertensive retinopathy
Hyperthermia
Hyperthyroidism
Hypertrophic cardiomyopathy
Hypoaldosteronism
Hypocalcemia
Hypochondrogenesis
Hypochondroplasia
Hypoglycemia
Hypogonadism
Hypokalemia
Hypokalemic periodic...
Hypoparathyroidism
Hypophosphatasia
Hypopituitarism
Hypoplastic left heart...
Hypoprothrombinemia
Hypothalamic dysfunction
Hypothermia
Hypothyroidism
Hypoxia
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Some hemoglobinopathies (and also related diseases like glucose-6-phosphate dehydrogenase deficiency) seem to have given an evolutionary benefit, especially to heterozygotes, in areas where malaria is endemic. Malaria parasites live inside red blood cells, but subtly disturb normal cellular function. In patients predisposed for rapid clearance of red blood cells, this may lead to early destruction of cells infected with the parasite and increased chance of survival for the carrier of the trait.

Despite the malaria link, Caucasians can be affected by hemoglobinopathies (thalassemia occurs in the Mediterranean countries), as can people from South America and India.

Diagnosis The diagnosis of each hemoglobinopathy is best approached using alkaline electophoresis (pH 8.6) and acid electophoresis (pH 6.2) in which is red cell lysate is put into cellulose acetate or agar support medium and placed in an electric field. Each hemoglobin band has a characteristic migration sequence based on mainly size and charge of the hemoglobin-agaropectin complex. Migration generally goes from the anode (-) to the cathode (+). These methods reliably separate Hemoglobin A (alpha2-beta2) from Hemoglobin S (alpha2-betaS2), Hemoglobin C (alpha2-betaC2), and others. Rare hemoglobin variants can be also isolated using these tests in combination with high performace liquid chromatography (HPLC). Other tests which are more esoteric exist such as globin chain electophoresis, isoelectric focusing, and DNA sequencing/amino acid sequencing, with the prior two tests showing greater resolution but still rely on electrophoresis for separation.

Globin chain electrophoreis is a method in which hemoglobin lysate is mixed with hydrochloric acid and acetone, the heme group is removed by repeated washing of the precipitated globin by acetone. The globin chains are dissociated into monomers by urea and then separated on the basis of charge differences by electophoresis at both acid (pH 6.2) and alkaline (pH 8.9) environments. This method is used as an extension to HPLC when both alpha chain variants and beta chain variants are present within the same individual (dual heterozygote).

Isoelectric focusing is an electrophoretic method which utilizes carrier ampholytes (small proteins which carry both charge and pH). These compounds have molecular weights of 300-1000 Daltons. The ampholytes are incorporated into the support medium (agar) and they establish a pH gradient when charged. High voltages are used to separate the ampholytes due to large concentrations within the medium. Each hemoglobin will travel until it's isoelectric point (zero charge) where migration stops. Isoelectric focusing gives better resolution than alkaline and acid electrophoresis and produce sharper bands. The resolution, however, does have a downside in that minor glycosylated hemoglobins and aging hemoglobins (methemoglobin, glycerated hemoglobin) may cause confusion.

Read more at Wikipedia.org


[List your site here Free!]


Nosing into flu season
From Nursing, 9/1/04

HEALTHY PEOPLE between ages 5 and 49 now have the option to receive annual flu vaccinations intranasally. Prepackaged in unit-dose sprayers for intranasal administration, the live attenuated influenza vaccine (LAIV) is formulated each year to protect against the same virus strains as the inactivated vaccine that's administered by intramuscular injection.

Follow the manufacturer's guidelines for freezing and defrosting the vaccine to maintain vaccine potency. Before administering LAIV take a thorough patient history, and don't administer it in these situations:

* patient with known or suspected immunodeficiency disease

* current aspirin or aspirin-containing therapy in children or adolescents, which would increase the risk of Reye's syndrome

* patient history of Guillain-Barré syndrome (warning applies to the inactivated vaccine too)

* patient history of hypersensitivity to any components of LAIV or to eggs (warning also applies to the inactivated vaccine)

* patient history of reactive airway disease or chronic cardiopulmonary disease

* anyone with a chronic medical condition such as diabetes, renal dysfunction, or hemoglobinopathy

* a pregnant woman

* anyone in close contact with a severely immunosuppressed person, such as a bone marrow transplant recipient, while that person is in a protective environment.

Administering LAIV

Have your patient sit upright. Explain the potential risks and benefits of receiving the vaccine, potential adverse reactions, and what to do if they should occur. Have epinephrine injection (1:1,000) or a comparable treatment handy to treat a potential acute anaphylactic reaction.

Learn how to administer influenza vaccine intranasally in a few steps.

BY THE EDITORS OF NURSING2004

1. Thaw the vaccine by holding the sprayer in the palm of your hand, as shown, with your thumb supporting but not depressing the plunger. Don't roll the sprayer between your palms, which could dislodge the dose divider clip. Thawing may take up to 3 minutes.

Another option is to thaw the vaccine in the refrigerator at 36° F to 46° F (2° C to 8° C) for up to 24 hours.

2. Make sure the divider clip is securely attached to the sprayer plunger. This separates the dose into two portions, one for each nostril.

3. Remove the protector from the sprayer tip. Have your patient tilt her head backward and advise her to breathe normally. Place the sprayer tip just inside her nostril and depress the plunger to deliver the first dose, as shown.

4. Pinch and remove the divider clip from the plunger. Place the sprayer tip just inside her other nostril and depress the plunger to deliver the remaining vaccine. Follow standard procedures for biohazardous waste to dispose of the sprayer.

Teach your patient the potential adverse reactions, what to do if they occur, and what medications to avoid. Document the date, time, and route of administration; the drug name, dose, lot number, and expiration date; and any teaching you provided.

SELECTED REFERENCE

Supplemental Recommendations of the Advisory Committee on Immunization Practices (ACIP): "Using Live, Attenuated Influenza Vaccine for Prevention and Control of Influenza," MMWR, 52(RR13):1-8. September 26 2003.

Copyright Springhouse Corporation Sep 2004
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Hemoglobinopathy
Home Contact Resources Exchange Links ebay